Banze, D.* ; Calderwood, C.J.* ; Nhamuave, C.* ; Marambire, E.T.* ; Mfinanga, A.* ; Larsson, L.* ; Malhotra, A.M.* ; Minja, L.T.* ; Ivanova, O.* ; Zurba, L.* ; Heinrich, N.* ; Ferrand, R.A.* ; Fielding, K.* ; Kranzer, K.* ; Rachow, A. ; Hurst, J.R.* ; Khosa, C.*
Implications of reference equations for interpretation of spirometry in three African countries: A cross-sectional study.
ERJ Open Res. 11:00932-2024 (2025)
BACKGROUND: The Global Lung Function Initiative (GLI) and American Thoracic Society recently endorsed a race-composite spirometry reference equation ("GLI Global"). Africa (outside North Africa) is not represented in the underlying dataset; GLI Global has not been evaluated in the region. We evaluated the fit and diagnostic implications of GLI and African (identified by scoping review) reference equations in three East/Southern African countries. METHODS: Among healthy participants from a tuberculosis household contact cohort study in Mozambique, Tanzania and Zimbabwe (age ≥10 years) with post-bronchodilator spirometry we calculated forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and FEV1/FVC z-scores using different equations, the proportion of people with obstructive airways disease or preserved-ratio-impaired spirometry by different equations. We compared these measures across reference equations. RESULTS: In total, 806 healthy people had good-quality post-bronchodilator spirometry. Across GLI equations, "African American" fitted best (mean±sd FEV1 z-score -0.12±1.20, mean FVC z-score -0.35±1.19). Compared with "African American", GLI Global resulted in twice as many people being identified as having preserved-ratio impaired spirometry (22% versus 11%) with a similar proportion having obstruction (4.2% versus 3.8%). Reference equations developed in Africa conferred similar fit compared with the GLI African American equation. CONCLUSIONS: Reference equations have clinical and public health implications that demand careful consideration, particularly in resource-constrained environments. Use of GLI Global may result more people being identified as having lung function impairment. Further work that includes clinical outcomes is needed to ensure that GLI Global is globally representative. The key limitation of this work is the potential for people with undiagnosed respiratory disease to have been included in the analysis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
American Thoracic Society; Reference Values; Lung; Tuberculosis
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2025
Prepublished im Jahr
0
HGF-Berichtsjahr
2025
ISSN (print) / ISBN
2312-0541
e-ISSN
2312-0541
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 11,
Heft: 4,
Seiten: ,
Artikelnummer: 00932-2024
Supplement: ,
Reihe
Verlag
European Respiratory Society
Verlagsort
[S.l.]
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Research Unit Global Health (UGH)
POF Topic(s)
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-540001-003
Förderungen
Wellcome Trust
German Center for Infection Research (DZIF)
European Union
European and Developing Countries Clinical Trials Partnership (EDCTP)
Copyright
Erfassungsdatum
2025-07-23